Montorfano Matteo Professore AssociatoMedicineMED/11 - MEDS-07/B - Malattie dell'apparato cardiovascolare

Professor Matteo Montorfano graduated in Medicine with summa cum laude at University of Milan, Italy, in 1991 and completed his Residency in Cardiolgy with honors in Rome at Università La Sapienza in 1998.

Since November 2018 he is the Director of the Interventional Cardiology Unit at San Raffaele Hospital in Milan, Italy. He has an extensive experience in every field of interventional cardiology (percutaneous coronary and peripheral vascular interventions, structural heart interventions).

From March 2023 he is Associate Professor of Cardiology at Vita-Salute San Raffaele University and Director of the Master in Interventional Cardiology.

He is co-author of around 450 publications in the most important scientific journals in his field (including Circulation, Journal of American College of Cardiology, JAMA, JACC Cardiovascular Intervention).

Until today, his scientific work received more than 15.000 citations with an H-index of 59.

He holds many patents regarding devices used in the treatment of heart valve disease and he is co-founder of two medical start up companies developing new tools for the treatment of structural heart disease.

Unique identifiers

ORCID ID: 0000-0001-9732-9459

Scopus Author ID: 7003659232

Google Scholar:  https://scholar.google.com/citations?user=MWVfuwsAAAAJ&hl=it

Education

1998 Residency in Cardiovascular Medicine, University “La Sapienza”, Rome, Italy

1991 School of Medicine, University of Milan, Italy

Positions and Training

2018 – today            Director of Interventional Cardiology Unit and Cardiac Catheterization

                                Laboratory, San Raffaele Hospital, Milan, Italy

2008 – 2018             Director of the Unit of percutaneous treatment of valve and structural

                                 Heart disease, San Raffaele Hospital Milan, Italy                                          

2000 – 2018           Director of the Catheterization Laboratory, Interventional

                                 Cardiology Unit, San Raffaele Hospital, Milan, Italy

1998 – 2000           Interventional Cardiology Consultant, Interventional Cardiology

                                 Unit, San Raffaele Hospital, Milan, Italy    

1993 – 1997             Cardiology Consultant, Cardiology Unit, San Raffaele Hospital, Milan,

                                 Italy

1991 – 1993           Cardiology Fellow, Cardiology Unit, San Raffaele Hospital, Milan, Italy

Teaching experience

March 2023 Associate Professor of Cardiology at Vita-Salute San Raffaele University, Milan, Italy

March 2023 Director of the Master in Interventional Cardiology, Vita-Salute San Raffaele University, Milan, Italy

2019 – 2022 Assistant Professor of Cardiology at Vita-Salute San Raffaele University, Milan, Italy

2019 – today Director of many courses with live demonstrations for the treatment of percutaneous and structural heart disease

Clinical Activity

Extensive experience in percutaneous coronary intervention, including complex lesions (bifurcations, unprotected left main, chronic total occlusions, calcific lesions requiring adjunctive devices, such as rotablator, intravascular lithotripsy and laser).

Extensive experience in structural heart intervention: transcatheter aortic valve implantation (TAVI), percutaneous repair of mitral valve, percutaneous atrial septal defect and patent foramen ovale closures, left atrial appendage closure and percutaneous closure of paravalvular leaks.

Research Activity

Pioneer of the treatment of structural heart disease:

- Planning and performance of the first-in-men mitral valve-in-valve intervention and improvement of the transeptal technique for the treatment of degenerated mitral bioprostheses

- Development of a new sizing method (the LIRA method) for the percutaneous treatment of the aortic stenosis in patients with bicuspid anatomy

Principal Investigator and co-investigator of major international trials

Holder of many patents for the treatment of structural heart disease

Co-Founder of two start-up companies for the percutaneous treatment of valvular disease: Cephea Valve Technologies (developing a transcatheter prosthetic mitral valve) and Viv-Heart (developing a catheter for the treatment of aortic stenosis).

Faculty member of major scientific meetings of the field (TCT, PCR, GISE)

Consultantship and Advisory Boards

Edwards Lifesciences

Abbott

Medtronic

Boston Scientific

Kardia